Aspire-Lakewood Holdings, Inc. (ASBP) analyst actions
Rating and price-target actions on ASBP in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ASBP overview →
1 measured ASBP analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation | Press release | -7.72% | +9.44% |
Keep exploring
More ASBP: earnings → · SEC filings → · ASBP overview →